<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.108260</article-id><article-id pub-id-type="publisher-id">ACM-37249</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200800000_77776443.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  抗菌肽的来源、作用机制及临床应用研究进展
  Sources, Mechanism and Clinical Application of Antimicrobial Peptides
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>吴</surname><given-names>阳开</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>金</surname><given-names>明昌</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>广东容大生物股份有限公司，广东 清远</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>08</month><year>2020</year></pub-date><volume>10</volume><issue>08</issue><fpage>1729</fpage><lpage>1942</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    抗菌肽(Antimicrobial peptide, AMPs)又叫宿主防御肽(Host defence peptide, HDPs)，通常是由7~100个氨基酸组成的小分子多肽，是生物体天然免疫防御系统的一个重要组成部分。AMPs具有广谱抗感染性细菌(G
   <sup>+</sup>、G
   <sup>−</sup>)、抗病毒、抗真菌、抗寄生虫、抑杀肿瘤细胞和免疫调节等生物学活性。AMPs通过膜作用和非膜作用两种机制抑杀病原菌。AMPs由于其潜在的治疗作用，近年来受到了人们的广泛关注。与传统的抗生素相比，AMPs具有不易产生耐药性、低毒性、生物多样性和直接攻击性的特点，AMPs被认为是后抗生素时代最有前途的新一代抗菌药物。目前已有60多种AMPs药物进入市场，数百种AMPs药物正处于临床试验阶段。文章综述了抗菌肽的来源、作用机制及在临床上的应用。
    Antimicrobial peptides (AMPs), also known as host defense peptides (HDPs), are usually small peptides composed of 7~100 amino acids, which are an important part of the natural immune defense system. AMPs have many biological activities, such as broad-spectrum anti-infective bacteria (G
   <sup>+</sup>, G
   <sup>−</sup>), antiviral, antifungal, antiparasitic, antitumor and immunomodulatory activities. AMPs can inhibit and kill pathogenic bacteria through membrane acting mechanism and non-membrane acting mechanism. AMPs have been widely concerned in recent years because of their potential therapeutic effects. Compared with traditional antibiotics, AMPs are not easy to produce drug resistance, low toxicity, biodiversity and direct attacking properties. AMPs are considered to be the most promising new generation of antibacterial agents in the post antibiotic era. At present, more than 60 AMPs drugs already reached the market and hundreds of novel therapeutic AMPs are in the clinical trials. This paper reviews the sources, mechanism and recent clinical application of antimicrobial peptides. 
  
 
</p></abstract><kwd-group><kwd>抗菌肽，抗生素耐药性，治疗药物，临床试验，免疫调节活性, Antimicrobial Peptides</kwd><kwd> Antibiotic Resistance</kwd><kwd> Therapeutic Drugs</kwd><kwd> Clinical Trials</kwd><kwd> Immunomodulatory Activity</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>抗菌肽的来源、作用机制及临床应用 研究进展</title><p>吴阳开，金明昌</p><p>广东容大生物股份有限公司，广东 清远</p><p>收稿日期：2020年8月3日；录用日期：2020年8月19日；发布日期：2020年8月26日</p><disp-formula id="hanspub.37249-formula85"><graphic xlink:href="//html.hanspub.org/file/31-1571485x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>抗菌肽(Antimicrobial peptide, AMPs)又叫宿主防御肽(Host defence peptide, HDPs)，通常是由7~100个氨基酸组成的小分子多肽，是生物体天然免疫防御系统的一个重要组成部分。AMPs具有广谱抗感染性细菌(G<sup>+</sup>、G<sup>−</sup>)、抗病毒、抗真菌、抗寄生虫、抑杀肿瘤细胞和免疫调节等生物学活性。AMPs通过膜作用和非膜作用两种机制抑杀病原菌。AMPs由于其潜在的治疗作用，近年来受到了人们的广泛关注。与传统的抗生素相比，AMPs具有不易产生耐药性、低毒性、生物多样性和直接攻击性的特点，AMPs被认为是后抗生素时代最有前途的新一代抗菌药物。目前已有60多种AMPs药物进入市场，数百种AMPs药物正处于临床试验阶段。文章综述了抗菌肽的来源、作用机制及在临床上的应用。</p><p>关键词 :抗菌肽，抗生素耐药性，治疗药物，临床试验，免疫调节活性</p><disp-formula id="hanspub.37249-formula86"><graphic xlink:href="//html.hanspub.org/file/31-1571485x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/31-1571485x7_hanspub.png" /> <img src="//html.hanspub.org/file/31-1571485x8_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>抗菌肽(Antimicrobial peptide, AMPs)又叫宿主防御肽(Host defence peptide, HDPs)，通常是由7~100个氨基酸组成的小分子多肽 [<xref ref-type="bibr" rid="hanspub.37249-ref1">1</xref>]，是生物体天然免疫防御系统的一个重要组成部分 [<xref ref-type="bibr" rid="hanspub.37249-ref2">2</xref>]，也是各种生物抵御入侵病原体的第一道防线 [<xref ref-type="bibr" rid="hanspub.37249-ref3">3</xref>]。AMPs具有广谱抗感染性细菌(G<sup>+</sup>、G<sup>−</sup>) [<xref ref-type="bibr" rid="hanspub.37249-ref4">4</xref>]、抗病毒 [<xref ref-type="bibr" rid="hanspub.37249-ref5">5</xref>]、抗真菌 [<xref ref-type="bibr" rid="hanspub.37249-ref6">6</xref>]、抗寄生虫 [<xref ref-type="bibr" rid="hanspub.37249-ref7">7</xref>]、抑杀肿瘤细胞 [<xref ref-type="bibr" rid="hanspub.37249-ref8">8</xref>] 和免疫调节 [<xref ref-type="bibr" rid="hanspub.37249-ref9">9</xref>] 等生物学活性。尽管大多数AMPs是阳离子肽，但在脊椎动物、无脊椎动物和植物中已经发现了一些阴离子AMPs (Malik等，2016) [<xref ref-type="bibr" rid="hanspub.37249-ref10">10</xref>]。根据AMPs的二级结构，AMPs可分为四大类：1) α-螺旋(α-helical)、2) β-折叠(β-Stranded)、3) β-发夹或环(β-hairpin or loop)和4) 延伸型肽(extended)，其中α-螺旋肽和β-折叠肽是最常见的(图1) [<xref ref-type="bibr" rid="hanspub.37249-ref11">11</xref>]。本文就抗菌肽的来源、作用机制及在临床上的应用作一综述。</p><p>图1. AMPs的二级结构。引自Ahmed T A E, Hammami R. (2019)</p></sec><sec id="s4"><title>2. 抗菌肽的来源</title><p>AMPs的发现可以追溯到1939年，当时，Dubos从土壤样本的芽孢杆菌(Bacillus)中分离出一种抗菌剂 [<xref ref-type="bibr" rid="hanspub.37249-ref12">12</xref>]，这种物质能预防小鼠肺炎球菌(Pneumococcus)的感染，后来被命名为gramicidin (短杆菌肽) [<xref ref-type="bibr" rid="hanspub.37249-ref13">13</xref>]。此后，从原核生物和真核生物中相继发现了许多AMPs [<xref ref-type="bibr" rid="hanspub.37249-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.37249-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.37249-ref16">16</xref>]，仅蛙皮肤中就发现了300多种AMPs [<xref ref-type="bibr" rid="hanspub.37249-ref15">15</xref>]。据APD抗菌肽数据库报道(截止2020年5月)，已经有3099种天然抗菌肽被鉴定、分离出来，其中来自于动物2359种(76.12%)、植物352种(11.36%)、细菌355种(11.46%)、真菌20种(0.65%)、原虫8种(0.26%)、古细菌5种(0.16%) [<xref ref-type="bibr" rid="hanspub.37249-ref17">17</xref>] (见图2)。表1总结了从各种生物中发现的部分AMPs。</p><p>图2. AMPs 的来源。引自http://aps.unmc.edu/ap/main.php (2020年5月)</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Some antimicrobial peptides from various organism</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle"  colspan="6"  >昆虫抗菌肽</th></tr></thead><tr><td align="center" valign="middle" >序号</td><td align="center" valign="middle" >抗菌肽名称</td><td align="center" valign="middle" >来源</td><td align="center" valign="middle" >氨基酸数量</td><td align="center" valign="middle" >抗菌活性</td><td align="center" valign="middle" >参考文献</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Acaloleptin</td><td align="center" valign="middle" >Acalolepta luxuriosa</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref18">18</xref>]</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Andropin</td><td align="center" valign="middle" >Drosophila melanogaster</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref19">19</xref>]</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Apidaecin IA</td><td align="center" valign="middle" >Apis mellifera</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref20">20</xref>]</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Cecropin</td><td align="center" valign="middle" >Hyalophora cecropia</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref21">21</xref>]</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >Defensin-α</td><td align="center" valign="middle" >Aedes aegypti</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref22">22</xref>]</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >Drosomycin</td><td align="center" valign="middle" >Drosophila melanogaster</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref23">23</xref>]</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >Holotricin</td><td align="center" valign="middle" >Holotrichia diomphalia</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref24">24</xref>]</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >Sapecin-α</td><td align="center" valign="middle" >Sarcophaga peregrine</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref25">25</xref>]</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >Tenicin 1</td><td align="center" valign="middle" >Tenebrio molitor</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref26">26</xref>]</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >Thanatin</td><td align="center" valign="middle" >Podisus maculiventris</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref27">27</xref>]</td></tr><tr><td align="center" valign="middle"  colspan="6"  >人体</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Cathelicidins</td><td align="center" valign="middle" >Human neutrophils</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >F, G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref28">28</xref>]</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Α Defensins</td><td align="center" valign="middle" >Human neutrophils</td><td align="center" valign="middle" >12~80</td><td align="center" valign="middle" >F, G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref29">29</xref>]</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Human Histatin 8</td><td align="center" valign="middle" >Homo sapiens</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >F, G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref30">30</xref>]</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >LL37</td><td align="center" valign="middle" >Neutrophils (Homo sapiens)</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >F, G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref31">31</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle"  colspan="6"  >动物</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Androctonin</td><td align="center" valign="middle" >Androctonus australis</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >F, G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref32">32</xref>]</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Bactenecin</td><td align="center" valign="middle" >Bovine Neutrophils</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref33">33</xref>]</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Brevinin</td><td align="center" valign="middle" >Rana brevipora porsa</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >F, G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref34">34</xref>]</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Buforin II</td><td align="center" valign="middle" >Bufo bufo gargarizans</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >F, G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref35">35</xref>]</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >Cupiennin</td><td align="center" valign="middle" >Cupiennius salei</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref36">36</xref>]</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >Dermaseptin S1</td><td align="center" valign="middle" >Phyllomedusa sauvagii</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref37">37</xref>]</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >Lycotoxin</td><td align="center" valign="middle" >Lycosa carolinensis</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref38">38</xref>]</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >Tachyplesins</td><td align="center" valign="middle" >Tachypleus tridentatus (horseshoe crab)</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref39">39</xref>]</td></tr><tr><td align="center" valign="middle"  colspan="6"  >植物</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Hevein</td><td align="center" valign="middle" >Latex of rubber trees</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref40">40</xref>]</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Purothionins</td><td align="center" valign="middle" >Wheat endosperm</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref41">41</xref>]</td></tr><tr><td align="center" valign="middle"  colspan="6"  >微生物</td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Nisin</td><td align="center" valign="middle" >Lactococcus lactis</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref42">42</xref>]</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Alamethicin</td><td align="center" valign="middle" >Trichoderma viride</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref43">43</xref>]</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Enterocin</td><td align="center" valign="middle" >Enterococcus</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref44">44</xref>]</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >Hominicin</td><td align="center" valign="middle" >Staphylococcus hominis MBBL 2-9</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref45">45</xref>]</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >Ericin S</td><td align="center" valign="middle" >Bacillus subtilis</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref46">46</xref>]</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >Plantaricin A</td><td align="center" valign="middle" >Lactobacillus plantarum</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref42">42</xref>]</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >Carnobacteriocin B2</td><td align="center" valign="middle" >Carnobacterium piscicola</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref47">47</xref>]</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >Leucocin A</td><td align="center" valign="middle" >Leuconostoc pseudomesenteroides</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref48">48</xref>]</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >Subtilin</td><td align="center" valign="middle" >Bacillus subtilis</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref49">49</xref>]</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >Pyrularia thionin</td><td align="center" valign="middle" >Pyrularia pubera</td><td align="center" valign="middle" >47</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref50">50</xref>]</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >Microcin J25</td><td align="center" valign="middle" >Escherichia coli AY25</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref51">51</xref>]</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >Gramicidin A</td><td align="center" valign="middle" >Bacillus brevis</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref52">52</xref>]</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >Pediocin PA-1/AcH</td><td align="center" valign="middle" >Pediococcus acidilactici PAC-1.0</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref53">53</xref>]</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >Mesentericin Y105</td><td align="center" valign="middle" >Leuconostoc mesenteroides</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref54">54</xref>]</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >Carnobacteriocin BM1</td><td align="center" valign="middle" >Carnobacterium piscicola LV17B</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref55">55</xref>]</td></tr><tr><td align="center" valign="middle" >16</td><td align="center" valign="middle" >Streptin 1</td><td align="center" valign="middle" >Bacillus subtilis A1/3</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref56">56</xref>]</td></tr><tr><td align="center" valign="middle" >17</td><td align="center" valign="middle" >Planosporicin</td><td align="center" valign="middle" >Planomonospora alba</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref57">57</xref>]</td></tr><tr><td align="center" valign="middle" >18</td><td align="center" valign="middle" >Gassericin A</td><td align="center" valign="middle" >Lactobacillus gasseri LA39</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref58">58</xref>]</td></tr><tr><td align="center" valign="middle" >19</td><td align="center" valign="middle" >Circularin A</td><td align="center" valign="middle" >Clostridium beijerinckii ATCC 25752</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref59">59</xref>]</td></tr><tr><td align="center" valign="middle" >20</td><td align="center" valign="middle" >Divercin V41</td><td align="center" valign="middle" >Carnobacterium divergens V41</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref60">60</xref>]</td></tr><tr><td align="center" valign="middle" >21</td><td align="center" valign="middle" >Listeriocin 743A</td><td align="center" valign="middle" >Listeria innocua 743</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref61">61</xref>]</td></tr><tr><td align="center" valign="middle" >22</td><td align="center" valign="middle" >Plantaricin C19</td><td align="center" valign="middle" >Lactobacillus plantarum C19</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref62">62</xref>]</td></tr><tr><td align="center" valign="middle" >23</td><td align="center" valign="middle" >Enterocin P</td><td align="center" valign="middle" >Enterococcus faecium P13</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref63">63</xref>]</td></tr><tr><td align="center" valign="middle" >24</td><td align="center" valign="middle" >Subtilosin A</td><td align="center" valign="middle" >Bacillus subtilis</td><td align="center" valign="middle" >35</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref64">64</xref>]</td></tr><tr><td align="center" valign="middle" >25</td><td align="center" valign="middle" >Plantaricin ASM1</td><td align="center" valign="middle" >Lactobacillus plantarum A-1</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >G<sup>+</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref62">62</xref>]</td></tr><tr><td align="center" valign="middle" >26</td><td align="center" valign="middle" >Lichenin</td><td align="center" valign="middle" >Bacillus licheniformis</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >G<sup>+</sup>, G<sup>−</sup></td><td align="center" valign="middle" >[<xref ref-type="bibr" rid="hanspub.37249-ref65">65</xref>]</td></tr></tbody></table></table-wrap></table-wrap-group><p>表1. 各种生物来源的部分抗菌肽</p><p>注：F——真菌；G<sup>+</sup>——革兰氏阳性菌；G<sup>−</sup>——革兰氏阴性菌。</p></sec><sec id="s5"><title>3. 抗菌肽的作用机制</title><p>一般来说，AMPs首先通过静电作用与细菌细胞膜相互吸引 [<xref ref-type="bibr" rid="hanspub.37249-ref66">66</xref>]。根据其作用方式，AMPs的作用机制可分为膜作用和非膜作用两种类型。</p><sec id="s5_1"><title>3.1. 膜作用机制</title><p>阳离子AMPs通过选择性相互作用与带负电的微生物外膜作用(Zhao等，2001 [<xref ref-type="bibr" rid="hanspub.37249-ref67">67</xref>]；Sani等，2016 [<xref ref-type="bibr" rid="hanspub.37249-ref68">68</xref>])，导致细胞膜破裂而引起细胞内物质的渗漏而杀死细胞(Da Costa 等，2015 [<xref ref-type="bibr" rid="hanspub.37249-ref69">69</xref>])。这些AMPs在与微生物细胞膜相互作用的过程中显示出结构和拓扑的动态性变化(Mingeot-Leclercq等，2016 [<xref ref-type="bibr" rid="hanspub.37249-ref70">70</xref>]；Haney等，2017 [<xref ref-type="bibr" rid="hanspub.37249-ref71">71</xref>])。目前，解释AMPs作用于细菌膜的机制，有桶板模型(barrel-stave model)、环形孔模型(toroidal-pore model)、地毯模型(carpet-like model) 聚合模型(aggregate model)。如图3所示(Nguyen等，2011 [<xref ref-type="bibr" rid="hanspub.37249-ref72">72</xref>])。</p><p>图3. AMPs初始吸附后作用于细胞膜的机制。引自Nguyen等(2011)和Da Costa等(2015)</p><sec id="s5_1_1"><title>3.1.1. 桶板模型(Barrel-Stave Model)</title><p>在该模型中，α-螺旋结构的AMPs与细胞膜结合后，促使更多的AMPs结合在细胞膜表面，AMPs由与细胞膜平行方向逐渐转为垂直方向，通过螺旋结构中的疏水区域，插入至磷脂双分子层中，形成“桶样”的穿膜通道(Yang等，2001 [<xref ref-type="bibr" rid="hanspub.37249-ref73">73</xref>]；Reddy等，2005 [<xref ref-type="bibr" rid="hanspub.37249-ref74">74</xref>])。更多AMPs分子的聚集增大了孔径，导致细胞内容物的外溢，最终导致细胞死亡(Brogden，2005 [<xref ref-type="bibr" rid="hanspub.37249-ref75">75</xref>])。</p></sec><sec id="s5_1_2"><title>3.1.2. 环形孔模型(Toroidal-Pore Model)</title><p>在环形孔模型中，AMPs的亲水段与细胞膜中磷脂的极性部分相互作用，并持续诱导脂质单层弯曲以获得稳定的曲率并形成环形孔(Melo等，2009 [<xref ref-type="bibr" rid="hanspub.37249-ref76">76</xref>])。当插入的AMPs的极性面与膜脂的极性头结合时，形成跨膜环形孔，孔内同时排列着肽和脂头基团(Brogden, 2005 [<xref ref-type="bibr" rid="hanspub.37249-ref75">75</xref>])。</p></sec><sec id="s5_1_3"><title>3.1.3. 地毯式模型(Carpet Model)</title><p>在该模型中，AMPs与靶膜表面结合，并以地毯状的形式覆盖。在AMPs达到特定阈值后，肽分子与磷脂头基结合，形成含有碎片的胶束而穿透膜(Melo等，2009 [<xref ref-type="bibr" rid="hanspub.37249-ref76">76</xref>])，最终导致细胞膜崩解和随后的细胞死亡(Gaspar等，2013 [<xref ref-type="bibr" rid="hanspub.37249-ref77">77</xref>])。</p></sec><sec id="s5_1_4"><title>3.1.4. 聚合模型(Aggregate Channel Model)</title><p>在该模型中，AMPs无特定取向地聚集在细胞膜表面，达到一定浓度后与膜磷脂分子形成类似胶状的肽–脂复合物，以类似洗涤剂的方式破坏脂质双层，形成跨膜的动态孔道(Wu等，1999 [<xref ref-type="bibr" rid="hanspub.37249-ref78">78</xref>])。</p></sec></sec><sec id="s5_2"><title>3.2. 非膜作用机制</title><p>一些AMPs即使在低浓度下，也不改变膜完整性，穿过膜脂质双层，靶向细胞内成分(Hancock等，2002 [<xref ref-type="bibr" rid="hanspub.37249-ref79">79</xref>])，通过影响细胞内代谢活动，如结合DNA，阻断酶活性，抑制DNA、RNA或蛋白质的合成等而杀死细菌(Cudic等，2002 [<xref ref-type="bibr" rid="hanspub.37249-ref80">80</xref>]；Krizsan等，2014 [<xref ref-type="bibr" rid="hanspub.37249-ref81">81</xref>]；Mansour等，2014 [<xref ref-type="bibr" rid="hanspub.37249-ref82">82</xref>]；Yeaman等，2003 [<xref ref-type="bibr" rid="hanspub.37249-ref83">83</xref>]。见图4 (Da Costa等，2015 [<xref ref-type="bibr" rid="hanspub.37249-ref69">69</xref>])。表2列出了部分作用于细胞内活性的抗菌肽。</p><p>图4. AMPs非膜作用机制。引自Da Costa等(2015)。A. 破坏细胞膜完整性；B. 阻断RNA合成；C. 抑制细胞壁结构蛋白连接所需酶的活性；D. 核糖体功能与蛋白质合成的抑制；E. 适当折叠所必需的伴侣蛋白的阻断；F. 靶向线粒体：1) 抑制细胞呼吸和诱导活性氧(ROS)的形成，2) 破坏线粒体膜完整性以及ATP和NADH的外排</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Some antimicrobial peptides acting on intracellular activit</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >序号</th><th align="center" valign="middle" >抗菌肽名称</th><th align="center" valign="middle" >细胞内靶点</th><th align="center" valign="middle" >参考文献</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >Buforin II, tachyplesin</td><td align="center" valign="middle" >与DNA结合</td><td align="center" valign="middle" >Carrera, 2017 [<xref ref-type="bibr" rid="hanspub.37249-ref84">84</xref>]</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >Pleurocidin,dermaseptin,PR-39, HNP-1, HNP-2,Indolicidin</td><td align="center" valign="middle" >抑制DNA、RNA和蛋白质的合成</td><td align="center" valign="middle" >Nagarajan, 2018 [<xref ref-type="bibr" rid="hanspub.37249-ref85">85</xref>]</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >Histatins, pyrrhocoricin, Drosocin, Apidaecin</td><td align="center" valign="middle" >抑制酶的活性</td><td align="center" valign="middle" >Le, 2017 [<xref ref-type="bibr" rid="hanspub.37249-ref86">86</xref>]</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >N-acetylmuramoyl-L-alanine Amidase</td><td align="center" valign="middle" >自溶素的活化</td><td align="center" valign="middle" >Gordon, 2005 [<xref ref-type="bibr" rid="hanspub.37249-ref87">87</xref>]</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >PR-39, PR-26, indolicidin, microcin 25</td><td align="center" valign="middle" >改变细胞质膜(抑制隔膜形成)</td><td align="center" valign="middle" >Mirski, 2017 [<xref ref-type="bibr" rid="hanspub.37249-ref88">88</xref>]</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >Mersacidin</td><td align="center" valign="middle" >抑制细胞壁的合成</td><td align="center" valign="middle" >Wuerth, 2017 [<xref ref-type="bibr" rid="hanspub.37249-ref89">89</xref>]</td></tr></tbody></table></table-wrap><p>表2. 部分作用于细胞内活性的抗菌肽</p></sec></sec><sec id="s6"><title>4. AMPS在临床上的应用</title><sec id="s6_1"><title>4.1. AMPS作为治疗局部感染的药物</title><p>目前，一些抗菌肽已用于治疗人的局部感染药物，如抗菌肽NEUPREX为rBPI21的注射制剂，用于治疗接受心脏直视手术的儿科患者和严重烧伤患者(Conlon, 2011) [<xref ref-type="bibr" rid="hanspub.37249-ref90">90</xref>]；重组肽HBD-2用于治疗在使用假体植入过程中获得的感染(Shin, 2013) [<xref ref-type="bibr" rid="hanspub.37249-ref91">91</xref>]；来源于两栖动物皮肤的肽，如白细胞介素(alyteserin)、灯盏花素(brevinin)、蛔虫毒素(ascaphin)、假丝酵素(pseudin)、卡氏菌素(kassinatuerin)和颞叶蛋白(temporin),已被有效地用于治疗由鲍曼不动杆菌(Acinetobacter baumannii)、肺炎克雷伯菌(Klebsiella pneumoniae)、大肠杆菌(Escherichia coli)、金黄色葡萄球菌(Staphylococcus aureus)、铜绿假单胞菌(Pseudomonas)，念珠菌(Candida spp.)等多重耐药菌株引起的局部感染(Migoń, 2018) [<xref ref-type="bibr" rid="hanspub.37249-ref92">92</xref>]；P113是另一种天然存在于唾液中的抗菌肽(Haney, 2018) [<xref ref-type="bibr" rid="hanspub.37249-ref93">93</xref>]，它以漱口液的形式用于治疗艾滋病毒(HIV)患者的口腔念珠菌病(Candidiasis)感染。Pexiganan用于治疗糖尿病足溃疡中的局部感染(Greber, 2017) [<xref ref-type="bibr" rid="hanspub.37249-ref94">94</xref>]；吲哚基肽的变体MX-226和MX-594AN (omiganan pentahcolitan，1%凝胶)分别用于治疗与使用导管相关的感染和治疗寻常痤疮(Sachdeva, 2017) [<xref ref-type="bibr" rid="hanspub.37249-ref95">95</xref>]。</p></sec><sec id="s6_2"><title>4.2. 临床试验中的AMPs</title><p>目前，超过60种AMPs药物投入市场，数百种新的治疗用AMPs正处于临床试验中(Lau, 2018) [<xref ref-type="bibr" rid="hanspub.37249-ref96">96</xref>] (见表3)。新出现的多肽技术，包括多功能肽、细胞穿透肽和肽–药物结合物，将拓宽AMPs在医学中的应用(Raucher, 2015) [<xref ref-type="bibr" rid="hanspub.37249-ref97">97</xref>]。</p><table-wrap-group id="3"><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Partial AMPs in clinical trial</title></caption><table-wrap id="3_1"><table><tbody><thead><tr><th align="center" valign="middle" >抗菌肽</th><th align="center" valign="middle" >公司名称</th><th align="center" valign="middle" >临床试验阶段</th><th align="center" valign="middle" >抗菌谱/作用模式</th><th align="center" valign="middle" >参考文献</th></tr></thead><tr><td align="center" valign="middle" >CZEN-002</td><td align="center" valign="middle" >Zengen</td><td align="center" valign="middle" >临床I/II期</td><td align="center" valign="middle" >GPB，GNP，念珠菌(Candida)/酵母调节机制，cAMP诱导的干扰，抗炎</td><td align="center" valign="middle" >Ghosh等，2015 [<xref ref-type="bibr" rid="hanspub.37249-ref98">98</xref>]</td></tr><tr><td align="center" valign="middle" >Daptomycin</td><td align="center" valign="middle" >Cubicin</td><td align="center" valign="middle" >已上市</td><td align="center" valign="middle" >GPB/膜电位去极化，蛋白质、DNA和RNA合成的抑制</td><td align="center" valign="middle" >Cortes-Penfield等，2018 [<xref ref-type="bibr" rid="hanspub.37249-ref99">99</xref>]</td></tr><tr><td align="center" valign="middle" >EA-230</td><td align="center" valign="middle" >Exponential biotherapies</td><td align="center" valign="middle" >临床I/II期</td><td align="center" valign="middle" >抗炎药/败血症与肾功能衰竭的保护</td><td align="center" valign="middle" >Gagliardini等，2017 [<xref ref-type="bibr" rid="hanspub.37249-ref100">100</xref>]</td></tr><tr><td align="center" valign="middle" >Pexiganan (MSI-78)</td><td align="center" valign="middle" >Genaera Corporation</td><td align="center" valign="middle" >临床III期</td><td align="center" valign="middle" >感染性糖尿病足溃疡</td><td align="center" valign="middle" >Jepson等，2016 [<xref ref-type="bibr" rid="hanspub.37249-ref101">101</xref>]</td></tr><tr><td align="center" valign="middle" >Omiganan</td><td align="center" valign="middle" >MIGENIX</td><td align="center" valign="middle" >临床II/III期</td><td align="center" valign="middle" >导管感染与酒渣鼻</td><td align="center" valign="middle" >Ng等，2017 [<xref ref-type="bibr" rid="hanspub.37249-ref102">102</xref>]</td></tr><tr><td align="center" valign="middle" >Lytixar (LTX-109)</td><td align="center" valign="middle" >Lytix Biopharma</td><td align="center" valign="middle" >临床I/II期</td><td align="center" valign="middle" >革兰氏阳性皮肤感染、脓疱病和金黄色葡萄球菌(S. aureus)鼻腔感染</td><td align="center" valign="middle" >Mohammad等，2015 [<xref ref-type="bibr" rid="hanspub.37249-ref103">103</xref>]</td></tr><tr><td align="center" valign="middle" >hlF1-11</td><td align="center" valign="middle" >AM-Pharma</td><td align="center" valign="middle" >临床I/II期</td><td align="center" valign="middle" >免疫复合造血干细胞移植受者的菌血症和真菌感染</td><td align="center" valign="middle" >Morici等，2016 [<xref ref-type="bibr" rid="hanspub.37249-ref104">104</xref>]</td></tr><tr><td align="center" valign="middle" >Novexatin (NP-213)</td><td align="center" valign="middle" >NovaBiotics</td><td align="center" valign="middle" >临床II期</td><td align="center" valign="middle" >真菌性指甲感染</td><td align="center" valign="middle" >Javia等，2018 [<xref ref-type="bibr" rid="hanspub.37249-ref105">105</xref>]</td></tr><tr><td align="center" valign="middle" >LL-37</td><td align="center" valign="middle" >Karolinska Institute</td><td align="center" valign="middle" >临床I/II期</td><td align="center" valign="middle" >下肢静脉溃疡难治症</td><td align="center" valign="middle" >De Lorenzi等，2017 [<xref ref-type="bibr" rid="hanspub.37249-ref106">106</xref>]</td></tr><tr><td align="center" valign="middle" >PAC-113</td><td align="center" valign="middle" >Demegen</td><td align="center" valign="middle" >临床II期</td><td align="center" valign="middle" >HIV血清阳性患者的口腔念珠菌病</td><td align="center" valign="middle" >Mohammad等，2015 [<xref ref-type="bibr" rid="hanspub.37249-ref103">103</xref>]</td></tr><tr><td align="center" valign="middle" >RDP-58</td><td align="center" valign="middle" >Genzyme</td><td align="center" valign="middle" >后临床II期</td><td align="center" valign="middle" >炎症性肠病</td><td align="center" valign="middle" >Menko等，2015 [<xref ref-type="bibr" rid="hanspub.37249-ref107">107</xref>]</td></tr><tr><td align="center" valign="middle" >MX-594AN</td><td align="center" valign="middle" >MIgenix</td><td align="center" valign="middle" >临床II期</td><td align="center" valign="middle" >寻常痤疮的局部治疗</td><td align="center" valign="middle" >Moorthy等，2018 [<xref ref-type="bibr" rid="hanspub.37249-ref108">108</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="3_2"><table><tbody><thead><tr><th align="center" valign="middle" >MX-226</th><th align="center" valign="middle" >Migenix</th><th align="center" valign="middle" >临床IIIb期</th><th align="center" valign="middle" >皮肤病相关感染</th><th align="center" valign="middle" >Deslouches, 2017 [<xref ref-type="bibr" rid="hanspub.37249-ref109">109</xref>]</th></tr></thead><tr><td align="center" valign="middle" >HB-1345</td><td align="center" valign="middle" >BioMedix</td><td align="center" valign="middle" >临床I前期</td><td align="center" valign="middle" >痤疮</td><td align="center" valign="middle" >D&#246;şler, 2017 [<xref ref-type="bibr" rid="hanspub.37249-ref110">110</xref>]</td></tr><tr><td align="center" valign="middle" >HB-107</td><td align="center" valign="middle" >Biopharmaceuticals</td><td align="center" valign="middle" >临床前期</td><td align="center" valign="middle" >伤口愈合</td><td align="center" valign="middle" >Mangoni, 2016 [<xref ref-type="bibr" rid="hanspub.37249-ref111">111</xref>]</td></tr><tr><td align="center" valign="middle" >Glutoxim</td><td align="center" valign="middle" >Pharma BAM</td><td align="center" valign="middle" >临床II期</td><td align="center" valign="middle" >肺结核</td><td align="center" valign="middle" >Krutetskaya, 2017 [<xref ref-type="bibr" rid="hanspub.37249-ref112">112</xref>]</td></tr><tr><td align="center" valign="middle" >IMX942</td><td align="center" valign="middle" >Inimex</td><td align="center" valign="middle" >临床IA前期</td><td align="center" valign="middle" >免疫调节与化疗患者发热的治疗</td><td align="center" valign="middle" >Gagliardini等，2017 [<xref ref-type="bibr" rid="hanspub.37249-ref100">100</xref>]</td></tr><tr><td align="center" valign="middle" >DPK-060</td><td align="center" valign="middle" >Promore Pharma</td><td align="center" valign="middle" >临床II期</td><td align="center" valign="middle" >特应性皮炎的治疗</td><td align="center" valign="middle" >Harvey, 2015 [<xref ref-type="bibr" rid="hanspub.37249-ref113">113</xref>]</td></tr><tr><td align="center" valign="middle" >POL7080</td><td align="center" valign="middle" >Polyphor Ltd</td><td align="center" valign="middle" >临床II期</td><td align="center" valign="middle" >非囊性纤维化支气管扩张症的治疗</td><td align="center" valign="middle" >Butler, 2017 [<xref ref-type="bibr" rid="hanspub.37249-ref114">114</xref>]</td></tr><tr><td align="center" valign="middle" >SB006</td><td align="center" valign="middle" >SpiderBiotech</td><td align="center" valign="middle" >临床前期</td><td align="center" valign="middle" >抗内毒素活性</td><td align="center" valign="middle" >Giuliani, 2007 [<xref ref-type="bibr" rid="hanspub.37249-ref115">115</xref>]</td></tr><tr><td align="center" valign="middle" >PL-5</td><td align="center" valign="middle" >江苏普莱医药生物技术有限公司</td><td align="center" valign="middle" >临床II期</td><td align="center" valign="middle" >皮肤感染</td><td align="center" valign="middle" >Feng, 2015 [<xref ref-type="bibr" rid="hanspub.37249-ref116">116</xref>]</td></tr><tr><td align="center" valign="middle" >金环蛇毒抗菌肽BF-30</td><td align="center" valign="middle" >苏州康尔生物医药有限公司</td><td align="center" valign="middle" >临床I~III期</td><td align="center" valign="middle" >细菌性阴道病</td><td align="center" valign="middle" >李惠钰，2019 [<xref ref-type="bibr" rid="hanspub.37249-ref117">117</xref>]</td></tr></tbody></table></table-wrap></table-wrap-group><p>表3. 临床试验中的部分AMPs</p></sec></sec><sec id="s7"><title>5. 总结</title><p>抗生素耐药性是世界第二大死亡原因，导致每年约70万人死亡，预计到2050年每年死于抗生素耐药性的人数将达到1000万，造成的经济损失约10万亿美元。抗生素耐药性是多方面、多层面的，革兰氏阳性菌和革兰氏阴性菌都对现有的抗菌药物产生了难以治愈的耐药性，如耐万古霉素的粪肠球菌(Enterococcus faecium)、阴沟肠杆菌(Enterobacter cloacae, MRSA)，耐碳青霉烯类的鲍曼不动杆菌(Acinetobacter baumannii)和耐第三代头孢菌素大肠杆菌(E. coli)、β-内酰胺酶的MDR菌株，耐碳青霉烯类铜绿假单胞菌(Pseudomonas aeruginosa)和分枝杆菌(Mycobacterium)。对碳青霉烯类抗生素耐药的肺炎克雷伯菌(Klebsiella pneumoniae)对美国批准用于治疗的26种抗生素均产生耐药性。抗生素耐药性在全球范围内的扩展和蔓延速度远远高于发现并最终批准用于临床的新抗生素的速度。目前已有相当部分的AMPs在临床应用或处于临床试验中。AMPs被认为是后抗生素时代最有前途的新一代抗菌药物。人们对AMPs的结构、理化性质以及对其活性的影响已有充分的了解，但对AMPs的作用机制以及其对细菌和宿主细胞的反应仍缺乏深入了解。这是未来AMPs在临床上普遍应用的主要瓶颈。</p></sec><sec id="s8"><title>文章引用</title><p>吴阳开,金明昌. 抗菌肽的来源、作用机制及临床应用研究进展Sources, Mechanism and Clinical Application of Antimicrobial Peptides[J]. 临床医学进展, 2020, 10(08): 1729-1942. https://doi.org/10.12677/ACM.2020.108260</p></sec><sec id="s9"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.37249-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ageitos, J.M., Sanchez-Perez, A., Calo-Mata, P., et al. (2017) Antimicrobial Peptides (AMPs): Ancient Compounds That Represent Novel Weapons in the Fight against Bacteria. Biochemical Pharmacology, 133, 117-138.  
&lt;br&gt;https://doi.org/10.1016/j.bcp.2016.09.018</mixed-citation></ref><ref id="hanspub.37249-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Harris, F., Dennison, S.R. and Phoenix, D.A. (2009) Anionic Antimicrobial Peptides from Eukaryotic Organisms. Current Protein Peptide Science, 10, 585-606. &lt;br&gt;https://doi.org/10.2174/138920309789630589</mixed-citation></ref><ref id="hanspub.37249-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Pasupuleti, M., Schmidtchen, A. and Malmsten, M. (2012) Antimicrobial Peptides: Key Components of the Innate Immune System. Critical Reviews in Biotechnology, 32, 143-171. &lt;br&gt;https://doi.org/10.3109/07388551.2011.594423</mixed-citation></ref><ref id="hanspub.37249-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Brogden, K.A. (2005) Antimicrobial Peptides: Pore Formers or Metabolic Inhibitors in Bacteria. Nature Reviews Microbiology, 3, 238-250. &lt;br&gt;https://doi.org/10.1038/nrmicro1098</mixed-citation></ref><ref id="hanspub.37249-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Y.D., Kung, C.W. and Chen, J.Y. (2010) Antiviral Activity by Fish Antimicrobial Peptides of Epinecid-in-1 and Hepcidin 1-5 against Nervous Necrosis Virus in Medaka. Peptides, 31, 1026-1033.  
&lt;br&gt;https://doi.org/10.1016/j.peptides.2010.02.025</mixed-citation></ref><ref id="hanspub.37249-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Lupetti, A., Van Dissel, J., Brouwer, C., et al. (2008) Human Antimicrobial Peptides’ Antifungal Activity against Aspergillus fumigatus. European Journal of Clinical Microbiology &amp; Infectious Diseases, 27, 1125-1129.  
&lt;br&gt;https://doi.org/10.1007/s10096-008-0553-z</mixed-citation></ref><ref id="hanspub.37249-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Vizioli, J. and Salzet, M. (2002) Antimicrobial Peptides versus Parasitic Infections. Trends in Parasitology, 18, 475-476. &lt;br&gt;https://doi.org/10.1016/S1471-4922(02)02428-5</mixed-citation></ref><ref id="hanspub.37249-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Hoskin, D.W. and Ramamoorthy, A. (2008) Studies on Anticancer Activities of Antimicrobial Peptides. Biochimica et Biophysica Acta (BBA) Biomembranes, 1778, 357-375. &lt;br&gt;https://doi.org/10.1016/j.bbamem.2007.11.008</mixed-citation></ref><ref id="hanspub.37249-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Hilchie, A.L., Wuerth, K. and Hancock, R.E. (2013) Immune Modulation by Multifaceted Cationic Host Defense (Antimicrobial) Peptides. Nature Chemical Biology, 9, 761-768. &lt;br&gt;https://doi.org/10.1038/nchembio.1393</mixed-citation></ref><ref id="hanspub.37249-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Malik, E., Dennison, S.R., Harris, F., et al. (2016) pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents. Pharmaceuticals (Basel), 9, 67.  
&lt;br&gt;https://doi.org/10.3390/ph9040067</mixed-citation></ref><ref id="hanspub.37249-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Ahmed, T.A.E. and Hammami, R. (2019) Recent Insights into Structure-Function Relationships of Antimicrobial Peptides. Journal of Food Biochemistry, 43, e12546. &lt;br&gt;https://doi.org/10.1111/jfbc.12546</mixed-citation></ref><ref id="hanspub.37249-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Dubos, R.J. (1939) Studies on a Bactericidal Agent Extracted from a Soil Bacillus: II. Protective Effect of the Bactericidal Agent against Experimental Pneumococcus Infections in Mice. Journal of Experimental Medicine, 70, 11-17.  
&lt;br&gt;https://doi.org/10.1084/jem.70.1.11</mixed-citation></ref><ref id="hanspub.37249-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Dubos, R.J. and Hotchkiss, R.D. (1941) The Production of Bactericidal Substances by Aerobic Sporulating Bacilli. Journal of Experimental Medicine, 73, 629-640. &lt;br&gt;https://doi.org/10.1084/jem.73.5.629</mixed-citation></ref><ref id="hanspub.37249-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Bednarska, N.G., Wren, B.W. and Willcocks, S.J. (2017) The Importance of the Glycosylation of Antimicrobial Peptides: Natural and Synthetic Approaches. Drug Discovery Today, 22, 919-926.  
&lt;br&gt;https://doi.org/10.1016/j.drudis.2017.02.001</mixed-citation></ref><ref id="hanspub.37249-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Conlon, B.P., Nakayasu, E.S., Fleck, L.E., et al. (2013) Activated ClpP Kills Persisters and Eradicates a Chronic Biofilm Infection. Nature, 503, 365-370. &lt;br&gt;https://doi.org/10.1038/nature12790</mixed-citation></ref><ref id="hanspub.37249-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Andrä, J., Berninghausen, O. and Leippe, M. (2001) Cecropins, Antibacterial Peptides from Insects and Mammals, Are Potently Fungicidal against Candida albicans. Medical Microbiology and Immunology (Berl.), 189, 169-173.  
&lt;br&gt;https://doi.org/10.1007/s430-001-8025-x</mixed-citation></ref><ref id="hanspub.37249-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">The Antimicrobial Peptide Database (APD). http://aps.unmc.edu/ap/main.php</mixed-citation></ref><ref id="hanspub.37249-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Vogel, H., Badapanda, C., Knorr, E., et al. (2014) RNA Sequencing Analysis Reveals Abundant Developmental Stage-Specific and Immunity-Related Genes in the Pollen Beetle Meligethes aeneus. Insect Molecular Biology, 23, 98-112. &lt;br&gt;https://doi.org/10.1111/imb.12067</mixed-citation></ref><ref id="hanspub.37249-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Abry, M.F., Kimenyi, K.M., Masiga, D., et al. (2017) Comparative Genomics Identifies Male Accessory Gland Proteins in Five Glossina Species. Wellcome Open Research, 2, 73. &lt;br&gt;https://doi.org/10.12688/wellcomeopenres.12445.1</mixed-citation></ref><ref id="hanspub.37249-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Farouk, A.E., Ahamed, N.T., AlZahrani, O., et al. (2017) Inducible Antimicrobial Compounds (Halal) Production in Honey Bee Larvae (Apis mellifera) from Rumaida, Taif by Injecting of Various Dead Microorganisms Extracts. Journal of Applied Biology &amp; Biotechnology, 5, 23-29.</mixed-citation></ref><ref id="hanspub.37249-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Lee, J. and Lee, D.G. (2015) Antimicrobial Peptides (AMPs) with Dual Mechanisms: Membrane Disruption and Apoptosis. Journal of Microbiology and Biotechnology, 25, 759-764. &lt;br&gt;https://doi.org/10.4014/jmb.1411.11058</mixed-citation></ref><ref id="hanspub.37249-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Price, D.P., Schilkey, F.D., Ulanov, A., et al. (2015) Small Mosquitoes, Large Implications: Crowding and Starvation Affects Gene Expression and Nutrient Accumulation in Aedes aegypti. Parasites &amp; Vectors, 8, 252.  
&lt;br&gt;https://doi.org/10.1186/s13071-015-0863-9</mixed-citation></ref><ref id="hanspub.37249-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Allocca, M., Zola, S. and Bellosta, P. (2018) The Fruit Fly, Drosophila Melanogaster: Modeling of Human Diseases (Part II). In: Drosophila Melanogaster-Model for Recent Advances in Genetics and Therapeutics, IntechOpen, London.  
&lt;br&gt;https://doi.org/10.5772/intechopen.73199</mixed-citation></ref><ref id="hanspub.37249-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Thiyonila, B., Reneeta, N.P., Kannan, M., et al. (2018) Dung Beetle Gut Microbes: Diversity, Metabolic and Immunity Related Roles in Host System. International Journal of Scientific Innovations, 1, 84-91.</mixed-citation></ref><ref id="hanspub.37249-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Manabe, T. and Kawasaki, K. (2017) D-Form KLKLLLLLKLK-NH2 Peptide Exerts Higher Antimicrobial Properties than Its L-Form Counterpart via an Association with Bacterial Cell Wall Components. Scientific Reports, 7, Article No. 43384. &lt;br&gt;https://doi.org/10.1038/srep43384</mixed-citation></ref><ref id="hanspub.37249-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Yang, Y.T., Lee, M.R., Lee, S., et al. (2018) Tenebrio molitor Gram-Negative-Binding Protein 3 (TmGNBP3) Is Essential for Inducing Downstream Antifungal Tenecin 1 Gene Expression against Infection with Beauveria bassiana JEF-007. Insect Science, 6, 969-977. &lt;br&gt;https://doi.org/10.1111/1744-7917.12482</mixed-citation></ref><ref id="hanspub.37249-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Duwadi, D., Shrestha, A., Yilma, B., et al. (2018) Identification and Screening of Potent Antimicrobial Peptides in Arthropod Genomes. Peptides, 103, 26-30. &lt;br&gt;https://doi.org/10.1016/j.peptides.2018.01.017</mixed-citation></ref><ref id="hanspub.37249-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Sheehan, G., Bergsson, G., McElvaney, N.G., et al. (2018) The Human Cathelicidin Antimicrobial Peptide LL-37 Promotes the Growth of the Pulmonary Pathogen Aspergillus fumigatus. Infection and Immunity, 86, IAI.00097-18.  
&lt;br&gt;https://doi.org/10.1128/IAI.00097-18</mixed-citation></ref><ref id="hanspub.37249-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Schaal, J.B., Maretzky, T., Tran, D.Q., et al. (2018) Macrocyclic θ-Defensins Suppress Tumor Necrosis Factor-α (TNF-α) Shedding by Inhibition of TNF-α Converting Enzyme. The Journal of Biological Chemistry, 293, 2725-2734.  
&lt;br&gt;https://doi.org/10.1074/jbc.RA117.000793</mixed-citation></ref><ref id="hanspub.37249-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Khurshid, Z., Najeeb, S., Mali, M., et al. (2017) Histatin Peptides: Pharmacological Functions and Their Applications in Dentistry. Saudi Pharmaceutical Journal, 25, 25-31. &lt;br&gt;https://doi.org/10.1016/j.jsps.2016.04.027</mixed-citation></ref><ref id="hanspub.37249-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Baxter, A.A., Lay, F.T., Poon, I.K.H., et al. (2017) Tumor Cell Membrane-Targeting Cationic Antimicrobial Peptides: Novel Insights into Mechanisms of Action and Therapeutic Prospects. Cellular and Molecular Life Sciences, 74, 3809-3825. &lt;br&gt;https://doi.org/10.1007/s00018-017-2604-z</mixed-citation></ref><ref id="hanspub.37249-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Panteleev, P.V., Balandin, S.V., Ivanov, V.T., et al. (2017) A Therapeutic Potential of Animal β-Hairpin Antimicrobial Peptides. Current Medicinal Chemistry, 24, 1724-1746. &lt;br&gt;https://doi.org/10.2174/0929867324666170424124416</mixed-citation></ref><ref id="hanspub.37249-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Young-Speirs, M., Drouin, D., Cavalcante, P.A., et al. (2018) Host Defense Cathelicidins in Cattle: Types, Production, Bioactive Functions and Potential Therapeutic and Diagnostic Applications. International Journal of Antimicrobial Agents, 51, 813-821. &lt;br&gt;https://doi.org/10.1016/j.ijantimicag.2018.02.006</mixed-citation></ref><ref id="hanspub.37249-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Savelyeva, A., Ghavami, S., Davoodpour, P., et al. (2014) An Overview of Brevinin Superfamily: Structure, Function and Clinical Perspectives. Advances in Experimental Medicine &amp; Biology, 818, 197-212.  
&lt;br&gt;https://doi.org/10.1007/978-1-4471-6458-6_10</mixed-citation></ref><ref id="hanspub.37249-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Sun, T., Zhan, B. and Gao, Y. (2015) A Novel Cathelicidin from Bufo Bufo gargarizans Cantor Showed Specific Activity to Its Habitat Bacteria. Gene, 571, 172-177. &lt;br&gt;https://doi.org/10.1016/j.gene.2015.06.034</mixed-citation></ref><ref id="hanspub.37249-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Upadhyay, R.K. (2018) Spider Venom Toxins, Its Purification, Solubilization, and Antimicrobial Activity. International Journal of Green Pharmacy, 12, S200-2014.</mixed-citation></ref><ref id="hanspub.37249-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Belmadani, A., Semlali, A. and Rouabhia, M. (2018) Dermaseptin! S1 Decreases Candida albicans Growth, Biofilm Formation and the Expression of Hyphal Wall Protein 1 and Aspartic Protease Genes. Journal of Applied Microbiology, 125, 72-83. &lt;br&gt;https://doi.org/10.1111/jam.13745</mixed-citation></ref><ref id="hanspub.37249-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Tahir, H.M., Zaheer, A., Khan, A.A., et al. (2018) Antibacterial Potential of Venom Extracted from Wolf Spider, Lycosa terrestris (Araneae: Lycosiade). Indian Journal of Animal Science, 52, 286-290.  
&lt;br&gt;https://doi.org/10.18805/ijar.v0iOF.8484</mixed-citation></ref><ref id="hanspub.37249-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Kuzmin, D.V., Emelianova, A.A., Kalashnikova, M.B., et al. (2017) Effect of N- and C-Terminal Modifications on Cytotoxic Properties of Antimicrobial Peptide Tachyplesin I. Bulletin of Experimental Biology and Medicine, 162, 754-757. &lt;br&gt;https://doi.org/10.1007/s10517-017-3705-2</mixed-citation></ref><ref id="hanspub.37249-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Coulen, S.C., Sanders, J.P. and Bruins, M.E. (2017) Valorisation of Proteins from Rubber Tree. Waste and Biomass Valorization, 8, 1027-1041. &lt;br&gt;https://doi.org/10.1007/s12649-016-9688-9</mixed-citation></ref><ref id="hanspub.37249-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Thao, H.T., Lan, N.T.N. and Mau, C.H. (2017) Overexpression of VrPDF1 Gene Confers Resistance to Weevils in Transgenic Mung Bean Plant. &lt;br&gt;https://doi.org/10.7287/peerj.preprints.3264v1</mixed-citation></ref><ref id="hanspub.37249-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Mills, S., Griffin, C., O’Connor, P.M., et al. (2017) A Multibacteriocin Cheese Starter System, Comprising Nisin and Lacticin 3147 in Lactococcus lactis, in Combination with Plantaricin from Lactobacillus plantarum. Applied and Environmental Microbiology, 83, 717-799. &lt;br&gt;https://doi.org/10.1128/AEM.00799-17</mixed-citation></ref><ref id="hanspub.37249-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Su, Z., Leitch, J.J., Abbasi, F., et al. (2017) EIS and PM-IRRAS Studies of Alamethicin Ion Channels in a Tethered Lipid Bilayer. Journal of Electroanalytical Chemistry, 812, 213-220. &lt;br&gt;https://doi.org/10.1016/j.jelechem.2017.12.039</mixed-citation></ref><ref id="hanspub.37249-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Braïek, O.B., Morandi, S., Cremonesi, P., et al. (2018) Biotechnological Potential, Probiotic and Safety Properties of Newly Isolated Enterocin-Producing Enterococcus lactis Strains. LWT, 92, 361-370.  
&lt;br&gt;https://doi.org/10.1016/j.lwt.2018.02.045</mixed-citation></ref><ref id="hanspub.37249-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Ebrahimipour, G.H., Khosravibabadi, Z., Sadeghi, H., et al. (2014) Isolation, Partial Purifification and Characterization of an Antimicrobial Compound, Produced by Bacillus atrophaeus. Jundishapur Journal of Microbiology, 7, e11802.  
&lt;br&gt;https://doi.org/10.5812/jjm.11802</mixed-citation></ref><ref id="hanspub.37249-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, G., Dang, S., Gupta, S., et al. (2018) Antibacterial Activity, Cytotoxicity, and the Mechanism of Action of Bacteriocin from Bacillus subtilis GAS101. Medical Principles and Practice, 27, 186-192.  
&lt;br&gt;https://doi.org/10.1159/000487306</mixed-citation></ref><ref id="hanspub.37249-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Hammi, I., Delalande, F., Belkhou, R., et al. (2016) Maltaricin CPN, a New Class IIa Bacteriocin Produced by Carnobacterium Maltaromaticum CPN Isolated from Mould-Ripened Cheese. Journal of Applied Microbiology, 121, 1268-1274. &lt;br&gt;https://doi.org/10.1111/jam.13248</mixed-citation></ref><ref id="hanspub.37249-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Chen, Y.S., Wu, H.C., Kuo, C.Y., et al. (2018) Leucocin C-607, a Novel Bacteriocin from the Multiple Bacteriocin-Producing Leuconostoc Pseudomesenteroides 607 Isolated from Persimmon. Probiotics and Antimicrobial Proteins, 10, 148-156. &lt;br&gt;https://doi.org/10.1007/s12602-017-9359-6</mixed-citation></ref><ref id="hanspub.37249-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Singh, R., Miriyala, S.S., Giri, L., et al. (2017) Identification of Unstructured Model for Subtilin Production through Bacillus subtilis Using Hybrid Genetic Algorithm. Process Biochemistry, 60, 1-12.  
&lt;br&gt;https://doi.org/10.1016/j.procbio.2017.06.005</mixed-citation></ref><ref id="hanspub.37249-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Guzmán-Rodríguez, J.J., Ochoa-Zarzosa, A., López-Gómez, R., et al. (2015) Plant Antimicrobial Peptides Aspotential Anticancer Agents. BioMed Research International, 2015, Article ID: 735087. &lt;br&gt;https://doi.org/10.1155/2015/735087</mixed-citation></ref><ref id="hanspub.37249-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, N., Pan, Y., Cheng, Z., et al. (2016) Lasso Peptide, a Highly Stable Structure and Designable Multi-Functional Backbone. Amino Acids, 48, 1347-1356. &lt;br&gt;https://doi.org/10.1007/s00726-016-2228-x</mixed-citation></ref><ref id="hanspub.37249-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Muhammad, S.A., Ali, A., Naz, A., et al. (2016) A New Broad-Spectrum Peptide Antibiotic Produced by Bacillus brevis Strain MH9 Isolated from Margalla Hills of Islamabad, Pakistan. International Journal of Peptide Research and Therapeutics, 22, 271-279. &lt;br&gt;https://doi.org/10.1007/s10989-015-9508-2</mixed-citation></ref><ref id="hanspub.37249-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Araújo, C., Muñoz-Atienza, E., Poeta, P., et al. (2016) Characterization of Pediococcus acidilactici Strains Isolated from Rainbow Trout (Oncorhynchus mykiss) Feed and Larvae: Safety, DNA Fingerprinting, and Bacteriocinogenicity. Diseases of Aquatic Organisms, 119, 129-143. &lt;br&gt;https://doi.org/10.3354/dao02992</mixed-citation></ref><ref id="hanspub.37249-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Arakawa, K., Yoshida, S., Aikawa, H., et al. (2016) Production of a Bacteriocin-Like in Hibitory Substance by Leuconostoc mesenteroides subsp. Dextranicum 213M0 Isolated from Mongolian Fermented Mare Milk, Airag. Animal Science Journal, 87, 449-456. &lt;br&gt;https://doi.org/10.1111/asj.12445</mixed-citation></ref><ref id="hanspub.37249-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Tulini, F.L., Lohans, C.T., Bordon, K.C., et al. (2014) Purification and Characterization of Antimicrobial Peptides from Fish Isolate Carnobacterium maltaromaticum C2: Carnobacteriocin X and Carnolysins A1 and A2. International Journal of Food Microbiology, 173, 81-88. &lt;br&gt;https://doi.org/10.1016/j.ijfoodmicro.2013.12.019</mixed-citation></ref><ref id="hanspub.37249-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Bosma, T.U.S. (2017) Bacterial Surface Display and Screening of Thioether-Bridge-Containing Peptides. U.S. Patent No. 9, 651, 558.</mixed-citation></ref><ref id="hanspub.37249-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Gajalakshmi, P. (2017) Selective Isolation and Characterization of Rare Actinomycetes Adopted in Glacier Soil of Manaliice Point and Its Activity against Mycobacterium spp. Journal of Microbiology and Biotechnology Research, 7, 1-10. &lt;br&gt;https://doi.org/10.24896/jmbr.2017751</mixed-citation></ref><ref id="hanspub.37249-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Maldonado-Barragán, A., Caballero-Guerrero, B., Martín, V., et al. (2016) Purification and Genetic Characterization of Gassericin E, a Novel Co-Culture Inducible Bacteriocin from Lactobacillus gasseri EV1461 Isolated from the Vagina of a Healthy Woman. BMC Microbial, 16, 37. &lt;br&gt;https://doi.org/10.1186/s12866-016-0663-1</mixed-citation></ref><ref id="hanspub.37249-ref59"><label>59</label><mixed-citation publication-type="other" xlink:type="simple">Perez, R.H., Ishibashi, N., Inoue, T., et al. (2016) Functional Analysis of Genes Involved in the Biosynthesis of Enterocin NKR-5-3B, a Novel Circular Bacteriocin. Journal of Bacteriology, 198, 291-300.  
&lt;br&gt;https://doi.org/10.1128/JB.00692-15</mixed-citation></ref><ref id="hanspub.37249-ref60"><label>60</label><mixed-citation publication-type="other" xlink:type="simple">Brillet-Viel, A., Pilet, M.F., Courcoux, P., et al. (2016) Optimization of Growth and Bacteriocin Activity of the Food Bioprotective Carnobacterium divergens V41 in an Animal Origin Protein Free Medium. Frontiers in Marine Science, 3, 128. &lt;br&gt;https://doi.org/10.3389/fmars.2016.00128</mixed-citation></ref><ref id="hanspub.37249-ref61"><label>61</label><mixed-citation publication-type="other" xlink:type="simple">Wan, X., Li, R., Saris, P.E., et al. (2013) Genetic Characterisation and Heterologous Expression of Leucocin C, a Class IIa Bacteriocin from Leuconostoc carnosum 4010. Applied Microbiology and Biotechnology, 97, 3509-3518.  
&lt;br&gt;https://doi.org/10.1007/s00253-012-4406-4</mixed-citation></ref><ref id="hanspub.37249-ref62"><label>62</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Y., Shang, N., Qin, Y., et al. (2018) The Complete Genome Sequence of Lactobacillus plantarum LPL-1, a Novel Antibacterial Probiotic Producing Class IIa Bacteriocin. Journal of Biotechnology, 266, 84-88.  
&lt;br&gt;https://doi.org/10.1016/j.jbiotec.2017.12.006</mixed-citation></ref><ref id="hanspub.37249-ref63"><label>63</label><mixed-citation publication-type="other" xlink:type="simple">Le, T.N., Do, T.H., Nguyen, T.N., et al. (2014) Expression and Simple Purification Strategy for the Generation of Antimicrobial Active Enterocin P from Enterococcus faecium Expressed in Escherichia coli ER2566. Iranian Journal of Biotechnology, 12, 17-25. &lt;br&gt;https://doi.org/10.15171/ijb.1154</mixed-citation></ref><ref id="hanspub.37249-ref64"><label>64</label><mixed-citation publication-type="other" xlink:type="simple">Venturina, D.H., Villegas, L.C., Perez, M.T.M., et al. (2016) Isolation and Identification of Subtilosin A-Producing Bacillus subtilis from Mongo Sprouts, Silage and Soil Samples in the Philippines. Asia Life Sciences, 25, 123-136.</mixed-citation></ref><ref id="hanspub.37249-ref65"><label>65</label><mixed-citation publication-type="other" xlink:type="simple">Bhat, S.G. (2018) Modelling and Computational Sequence Analysis of a Bacteriocin Isolated from Bacillus licheniformis Strain BTHT. International Journal for Computational Biology, 7, 29-34.  
&lt;br&gt;https://doi.org/10.34040/IJCB.7.1.2018.93</mixed-citation></ref><ref id="hanspub.37249-ref66"><label>66</label><mixed-citation publication-type="other" xlink:type="simple">Hollmann, A., Martinez, M., Maturana, P., et al. (2018) Antimicrobial Peptides: Interaction with Model and Biological Membranes and Synergism with Chemical Antibiotics. Frontiers in Chemistry, 6, 204.  
&lt;br&gt;https://doi.org/10.3389/fchem.2018.00204</mixed-citation></ref><ref id="hanspub.37249-ref67"><label>67</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, H., Mattila, J.P., Holopainen, J.M., et al. (2001) Comparison of the Membrane Association of Two Antimicrobial Peptides, Magainin 2 and Indolicidin. Biophysical Journal, 81, 2979-2991.  
&lt;br&gt;https://doi.org/10.1016/S0006-3495(01)75938-3</mixed-citation></ref><ref id="hanspub.37249-ref68"><label>68</label><mixed-citation publication-type="other" xlink:type="simple">Sani, M.A. and Separovic, F. (2016) How Membrane-Active Peptides Get into Lipid Membranes. Accounts of Chemical Research, 49, 1130-1138. &lt;br&gt;https://doi.org/10.1021/acs.accounts.6b00074</mixed-citation></ref><ref id="hanspub.37249-ref69"><label>69</label><mixed-citation publication-type="other" xlink:type="simple">Da Costa, J.P., Cova, M., Ferreira, R., et al. (2015) Antimicrobial Peptides: An Alternative for Innovative Medicines? Applied Microbiology and Biotechnology, 99, 2023-2040. &lt;br&gt;https://doi.org/10.1007/s00253-015-6375-x</mixed-citation></ref><ref id="hanspub.37249-ref70"><label>70</label><mixed-citation publication-type="other" xlink:type="simple">Mingeot-Leclercq, M.P. and Décout, J.L. (2016) Bacterial Lipid Membranes as Promising Targets to Fight Antimicrobial Resistance, Molecular Foundations and Illustration through the Renewal of Aminoglycoside Antibiotics and Emergence of Amphiphilic Aminoglycosides. Medicinal Chemistry Communications, 7, 586-611.  
&lt;br&gt;https://doi.org/10.1039/C5MD00503E</mixed-citation></ref><ref id="hanspub.37249-ref71"><label>71</label><mixed-citation publication-type="other" xlink:type="simple">Haney, E.F., Mansour, S.C. and Hancock, R.E.W. (2017) Antimicrobial Peptides: An Introduction. In: Methods in Molecular Biology, Vol. 1548, Humana Press, Totowa, 3-22. &lt;br&gt;https://doi.org/10.1007/978-1-4939-6737-7_1</mixed-citation></ref><ref id="hanspub.37249-ref72"><label>72</label><mixed-citation publication-type="other" xlink:type="simple">Nguyen, L.T., Haney, E.F. and Vogel, H.J. (2011) The Expanding Scope of Antimicrobial Peptide Structures and Their Modes of Action. Trends in Biotechnology, 29, 464-472. &lt;br&gt;https://doi.org/10.1016/j.tibtech.2011.05.001</mixed-citation></ref><ref id="hanspub.37249-ref73"><label>73</label><mixed-citation publication-type="other" xlink:type="simple">Yang, L., Harroun, T.A., Weiss, T.M., et al. (2001) Barrel-Stave Model or Toroidal Model? A Case Study on Melittin Pores. Biophysical Journal, 81, 1475-1485. &lt;br&gt;https://doi.org/10.1016/S0006-3495(01)75802-X</mixed-citation></ref><ref id="hanspub.37249-ref74"><label>74</label><mixed-citation publication-type="other" xlink:type="simple">Reddy, K., Yedery, R. and Aranha, C. (2005) Antimicrobial Peptides: Premises and Promises. International Journal of Antimicrobial Agents, 24, 536-547. &lt;br&gt;https://doi.org/10.1016/j.ijantimicag.2004.09.005</mixed-citation></ref><ref id="hanspub.37249-ref75"><label>75</label><mixed-citation publication-type="other" xlink:type="simple">Brogden, K.A. (2005) Antimicrobial Peptides: Pore Formers or Metabolic Inhibitors in Bacteria. Nature Reviews Microbiology, 3, 238-250. &lt;br&gt;https://doi.org/10.1038/nrmicro1098</mixed-citation></ref><ref id="hanspub.37249-ref76"><label>76</label><mixed-citation publication-type="other" xlink:type="simple">Melo, M.N., Ferre, R. and Castanho, M.A. (2009) Antimicrobial Peptides: Linking Partition, Activity and High Membrane-Bound Concentrations. Nature Reviews Microbiology, 7, 245-250. &lt;br&gt;https://doi.org/10.1038/nrmicro2095</mixed-citation></ref><ref id="hanspub.37249-ref77"><label>77</label><mixed-citation publication-type="other" xlink:type="simple">Gaspar, D., Veiga, A.S. and Castanho, M.A. (2013) From Antimicrobial to Anticancer Peptides. A Review. Frontiers in Microbiology, 4, 294. &lt;br&gt;https://doi.org/10.3389/fmicb.2013.00294</mixed-citation></ref><ref id="hanspub.37249-ref78"><label>78</label><mixed-citation publication-type="other" xlink:type="simple">Wu, M.H., Maier, E., Benz, R., et al. (1999) Mechanism of Interaction of Different Classes of Cationic Antimicrobial Peptides with Planar Bilayers and with the Cytoplasmic Membrane of Escherichia coli. Biochemistry, 38, 7235-7242.  
&lt;br&gt;https://doi.org/10.1021/bi9826299</mixed-citation></ref><ref id="hanspub.37249-ref79"><label>79</label><mixed-citation publication-type="other" xlink:type="simple">Hancock, R.E.W. and Patrzykat, A. (2002) Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics. Current Drug Targets—Infectious Disorders, 2, 79-83. &lt;br&gt;https://doi.org/10.2174/1568005024605855</mixed-citation></ref><ref id="hanspub.37249-ref80"><label>80</label><mixed-citation publication-type="other" xlink:type="simple">Cudic, M. and Otvos, L. (2002) Intracellular Targets of Antibacterial Peptides. Current Drug Targets, 3, 101-106.  
&lt;br&gt;https://doi.org/10.2174/1389450024605445</mixed-citation></ref><ref id="hanspub.37249-ref81"><label>81</label><mixed-citation publication-type="other" xlink:type="simple">Krizsan, A., Volke, D., Weinert, S., et al. (2014) Insect-Derived Proline-Rich Antimicrobial Peptides Kill Bacteria by Inhibiting Bacterial Protein Translation at the 70S Ribosome. Angewandte Chemie International Edition in English, 53, 12236-12239. &lt;br&gt;https://doi.org/10.1002/anie.201407145</mixed-citation></ref><ref id="hanspub.37249-ref82"><label>82</label><mixed-citation publication-type="other" xlink:type="simple">Mansour, S.C., Pena, O.M. and Hancock, R.E. (2014) Host Defense Peptides: Frontline Immunomodulators. Trends in Immunology, 35, 443-450. &lt;br&gt;https://doi.org/10.1016/j.it.2014.07.004</mixed-citation></ref><ref id="hanspub.37249-ref83"><label>83</label><mixed-citation publication-type="other" xlink:type="simple">Yeaman, M.R. and Yount, N.Y. (2003) Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacological Reviews, 55, 27-55. &lt;br&gt;https://doi.org/10.1124/pr.55.1.2</mixed-citation></ref><ref id="hanspub.37249-ref84"><label>84</label><mixed-citation publication-type="other" xlink:type="simple">Carrera, M., Böhme, K., Gallardo, J.M., et al. (2017) Characterization of Foodborne Strains of Staphylococcus aureus by Shotgun Proteomics: Functional Net Works, Virulence Factors and Species-Specific Peptide Biomarkers. Frontiers in Microbiology, 8, 2458. &lt;br&gt;https://doi.org/10.3389/fmicb.2017.02458</mixed-citation></ref><ref id="hanspub.37249-ref85"><label>85</label><mixed-citation publication-type="other" xlink:type="simple">Nagarajan, K., Marimuthu, S.K., Palanisamy, S., et al. (2018) Peptide Therapeutics versus Superbugs: Highlight on Current Research and Advancements. International Journal of Peptide Research and Therapeutics, 24, 19-33.  
&lt;br&gt;https://doi.org/10.1007/s10989-017-9650-0</mixed-citation></ref><ref id="hanspub.37249-ref86"><label>86</label><mixed-citation publication-type="other" xlink:type="simple">Le, C.F., Fang, C.M. and Sekaran, S.D. (2017) Intracellular Targeting Mechanisms by Antimicrobial Peptides. Antimicrobial Agents and Chemotherapy, 61, e02340-16. &lt;br&gt;https://doi.org/10.1128/AAC.02340-16</mixed-citation></ref><ref id="hanspub.37249-ref87"><label>87</label><mixed-citation publication-type="other" xlink:type="simple">Gordon, Y.J., Romanowski, E.G. and McDermott, A.M. (2005) A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs. Current Eye Research, 30, 505-515.  
&lt;br&gt;https://doi.org/10.1080/02713680590968637</mixed-citation></ref><ref id="hanspub.37249-ref88"><label>88</label><mixed-citation publication-type="other" xlink:type="simple">Mirski, T., Niemcewicz, M., Bartoszcze, M., et al. (2017) Utilisation of Peptides against Microbial Infections—A Review. Annals of Agricultural and Environmental Medicine, 25, 205-210. &lt;br&gt;https://doi.org/10.26444/aaem/74471</mixed-citation></ref><ref id="hanspub.37249-ref89"><label>89</label><mixed-citation publication-type="other" xlink:type="simple">Wuerth, K. (2017) Combating Pseudomonas aeruginosa Lung Infections Using Synthetic Host Defense Peptides. Doctoral Dissertation, University of British Columbia, Vancouver.</mixed-citation></ref><ref id="hanspub.37249-ref90"><label>90</label><mixed-citation publication-type="other" xlink:type="simple">Conlon, J.M. and Sonnevend, A. (2011) Clinical Applications of Amphibian Antimicrobial Peptides. Journal of Medical Sciences, 4, 62-72. &lt;br&gt;https://doi.org/10.2174/1996327001104020062</mixed-citation></ref><ref id="hanspub.37249-ref91"><label>91</label><mixed-citation publication-type="other" xlink:type="simple">Shin, S.H., Lee, Y.S., Shin, Y.P., et al. (2013) Therapeutic Efficacy of Halocidinderived Peptide HG1 in a Mouse Model of Candida albicans Oral Infection. Journal of Antimicrobial Chemotherapy, 68, 1152-1160.  
&lt;br&gt;https://doi.org/10.1093/jac/dks513</mixed-citation></ref><ref id="hanspub.37249-ref92"><label>92</label><mixed-citation publication-type="other" xlink:type="simple">Migoń, D., Neubauer, D. and Kamysz, W. (2018) Hydrocarbon Stapled Antimicrobial Peptides. The Protein Journal, 37, 2-12. &lt;br&gt;https://doi.org/10.1007/s10930-018-9755-0</mixed-citation></ref><ref id="hanspub.37249-ref93"><label>93</label><mixed-citation publication-type="other" xlink:type="simple">Haney, E.F., Pletzer, D. and Hancock, R.E. (2018) Impact of Host Defense Peptides on Chronic Wounds and Infections. In: Recent Clinical Techniques, Results, and Research in Wounds, Springer, Cham, 1-17.  
&lt;br&gt;https://doi.org/10.1007/15695_2017_88</mixed-citation></ref><ref id="hanspub.37249-ref94"><label>94</label><mixed-citation publication-type="other" xlink:type="simple">Greber, K.E. and Dawgul, M. (2017) Antimicrobial Peptides under Clinical Trials. Current Topics in Medicinal Chemistry, 17, 620-628. &lt;br&gt;https://doi.org/10.2174/1568026616666160713143331</mixed-citation></ref><ref id="hanspub.37249-ref95"><label>95</label><mixed-citation publication-type="other" xlink:type="simple">Sachdeva, S. (2017) Peptides as “Drugs”: The Journey So Far. International Journal of Peptide Research and Therapeutics, 23, 49-60. &lt;br&gt;https://doi.org/10.1007/s10989-016-9534-8</mixed-citation></ref><ref id="hanspub.37249-ref96"><label>96</label><mixed-citation publication-type="other" xlink:type="simple">Lau, J.L. and Dunn, M.K. (2018) Therapeutic Peptides: Historical Perspectives, Current Development Trends, and Future Directions. Bioorganic &amp; Medicinal Chemistry, 26, 2700-2707. &lt;br&gt;https://doi.org/10.1016/j.bmc.2017.06.052</mixed-citation></ref><ref id="hanspub.37249-ref97"><label>97</label><mixed-citation publication-type="other" xlink:type="simple">Raucher, D. and Ryu, J.S. (2015) Cell-Penetrating Peptides: Strategies for Anticancer Treatment. Trends in Molecular Medicine, 21, 560-570. &lt;br&gt;https://doi.org/10.1016/j.molmed.2015.06.005</mixed-citation></ref><ref id="hanspub.37249-ref98"><label>98</label><mixed-citation publication-type="other" xlink:type="simple">Ghosh, C. and Haldar, J. (2015) Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides. ChemMedChem, 10, 1606-1624. &lt;br&gt;https://doi.org/10.1002/cmdc.201500299</mixed-citation></ref><ref id="hanspub.37249-ref99"><label>99</label><mixed-citation publication-type="other" xlink:type="simple">Cortes-Penfield, N., Oliver, N.T., Hunter, A., et al. (2018) Daptomycin and Combination Daptomycin-Ceftaroline as Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia. The Journal of Infectious Diseases (London), 50, 643-647. &lt;br&gt;https://doi.org/10.1080/23744235.2018.1448110</mixed-citation></ref><ref id="hanspub.37249-ref100"><label>100</label><mixed-citation publication-type="other" xlink:type="simple">Gagliardini, E., Benigni, A. and Perico, N. (2017) Pharmacological Induction of Kidney Regeneration. In: Orlando, G., Remuzzi, G. and Williams, D.F., Eds., Kidney Transplantation, Bioengineering and Regeneration, Academic Press, Cambridge, 1025-1037. &lt;br&gt;https://doi.org/10.1016/B978-0-12-801734-0.00074-6</mixed-citation></ref><ref id="hanspub.37249-ref101"><label>101</label><mixed-citation publication-type="other" xlink:type="simple">Jepson, A.K., Schwarz-Linek, J., Ryan, L., et al. (2016) What Is the “Minimum Inhibitory Concentration” (MIC) of Pexiganan Acting on Escherichia coli? A Cautionary Case Study. Advances in Experimental Medicine and Biology, 915, 33-48. &lt;br&gt;https://doi.org/10.1007/978-3-319-32189-9_4</mixed-citation></ref><ref id="hanspub.37249-ref102"><label>102</label><mixed-citation publication-type="other" xlink:type="simple">Ng, S.M.S., Teo, S.W., Yong, Y.E., et al. (2017) Preliminary Investigations into Developing All-D Omiganan for Treating Mupirocin-Resistant MRSA Skin Infections. Chemical Biology &amp; Drug Design, 90, 1155-1160.  
&lt;br&gt;https://doi.org/10.1111/cbdd.13035</mixed-citation></ref><ref id="hanspub.37249-ref103"><label>103</label><mixed-citation publication-type="other" xlink:type="simple">Mohammad, H., Thangamani, S. and Seleem, M.N. (2015) Antimicrobial Peptides and Peptidomimetics-Potent Therapeutic Allies for Staphylococcal Infections. Current Pharmaceutical Design, 21, 2073-2088.  
&lt;br&gt;https://doi.org/10.2174/1381612821666150310102702</mixed-citation></ref><ref id="hanspub.37249-ref104"><label>104</label><mixed-citation publication-type="other" xlink:type="simple">Morici, P., Fais, R., Rizzato, C., et al. (2016) Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11. PLoS ONE, 11, e0167470. &lt;br&gt;https://doi.org/10.1371/journal.pone.0167470</mixed-citation></ref><ref id="hanspub.37249-ref105"><label>105</label><mixed-citation publication-type="other" xlink:type="simple">Javia, A., Amrutiya, J., Lalani, R., et al. (2018) Antimicrobial Peptide Delivery: An Emerging Therapeutic for the Treatment of Burn and Wounds. Therapeutic Delivery, 9, 375-386. &lt;br&gt;https://doi.org/10.4155/tde-2017-0061</mixed-citation></ref><ref id="hanspub.37249-ref106"><label>106</label><mixed-citation publication-type="other" xlink:type="simple">De Lorenzi, E., Chiari, M., Colombo, R., et al. (2018) Evidence That the Human Innate Immune Peptide LL-37 May Be a Binding Partner of Abeta and Inhibitor of Fibril Assembly. Biophysical Journal, 114, 393a.  
&lt;br&gt;https://doi.org/10.1016/j.bpj.2017.11.2174</mixed-citation></ref><ref id="hanspub.37249-ref107"><label>107</label><mixed-citation publication-type="other" xlink:type="simple">Menko, A.S. (2015) Method to Treat and Prevent Posterior Capsule Opacification. Patent 8, 999, 370.</mixed-citation></ref><ref id="hanspub.37249-ref108"><label>108</label><mixed-citation publication-type="other" xlink:type="simple">Moorthy, N.S.H.N., Pratheepa, V. and Manivannan, E. (2018) Natural Product Derived Drugs for Immunological and Inflammatory Diseases. Natural Products in Clinical Trials, 1, 1-31.  
&lt;br&gt;https://doi.org/10.2174/9781681082134118010004</mixed-citation></ref><ref id="hanspub.37249-ref109"><label>109</label><mixed-citation publication-type="other" xlink:type="simple">Deslouches, B. and Di, Y.P. (2017) Antimicrobial Peptides with Selective Antitumor Mechanisms: Prospect for Anticancer Applications. Oncotarget, 8, 46635-46651. &lt;br&gt;https://doi.org/10.18632/oncotarget.16743</mixed-citation></ref><ref id="hanspub.37249-ref110"><label>110</label><mixed-citation publication-type="other" xlink:type="simple">Dösler, S. (2017) Antimicrobial Peptides: Coming to the End of Antibiotic Era, the Most Promising Agents. İstanbul Journal of Pharmacy, 47, 72-76. &lt;br&gt;https://doi.org/10.5152/IstanbulJPharm.2017.0012</mixed-citation></ref><ref id="hanspub.37249-ref111"><label>111</label><mixed-citation publication-type="other" xlink:type="simple">Mangoni, M.L., McDermott, A.M. and Zasloff, M. (2016) Antimicrobial Peptides and Wound Healing: Biological and Therapeutic Considerations. Experimental Dermatology, 25, 167-173. &lt;br&gt;https://doi.org/10.1111/exd.12929</mixed-citation></ref><ref id="hanspub.37249-ref112"><label>112</label><mixed-citation publication-type="other" xlink:type="simple">Krutetskaya, Z.I., Melnitskaya, A.V., Antonov, V.G., et al. (2017) Lipoxygenases Modulate the Effect of Glutoxim on Na+ Transport in the Frog Skin Epithelium. Doklady Biochemistry and Biophysics, 474, 193-195.  
&lt;br&gt;https://doi.org/10.1134/S1607672917030073</mixed-citation></ref><ref id="hanspub.37249-ref113"><label>113</label><mixed-citation publication-type="other" xlink:type="simple">Harvey, A., Edrada-Ebel, R. and Quinn, R.J. (2015) The Re-Emergence of Natural Products for Drug Discovery in the Genomics Era. Nature Reviews Drug Discovery, 14, 111-129. &lt;br&gt;https://doi.org/10.1038/nrd4510</mixed-citation></ref><ref id="hanspub.37249-ref114"><label>114</label><mixed-citation publication-type="other" xlink:type="simple">Butler, M.S., Blaskovich, M.A. and Cooper, M.A. (2017) Antibiotics in the Clinical Pipeline at the End of 2015. The Journal of Antibiotics (Tokyo), 70, 3-24. &lt;br&gt;https://doi.org/10.1038/ja.2016.72</mixed-citation></ref><ref id="hanspub.37249-ref115"><label>115</label><mixed-citation publication-type="other" xlink:type="simple">Giuliani, A., Pirri, G. and Nicoletto, S. (2007) Antimicrobial Peptides: An Overview of a Promising Class of Therapeutics. Open Life Sciences, 2, 1-33. &lt;br&gt;https://doi.org/10.2478/s11535-007-0010-5</mixed-citation></ref><ref id="hanspub.37249-ref116"><label>116</label><mixed-citation publication-type="other" xlink:type="simple">Feng, Q., Huang, Y. and Chen, M. (2015) Functional Synergy of α-Helical Antimicrobial Peptides and Traditional Antibiotics against Gram-Negative and Gram-Positive Bacteria in Vitro and in Vivo. European Journal of Clinical Microbiology &amp; Infectious Diseases, 34, 197-204. &lt;br&gt;https://doi.org/10.1007/s10096-014-2219-3</mixed-citation></ref><ref id="hanspub.37249-ref117"><label>117</label><mixed-citation publication-type="other" xlink:type="simple">李惠钰. 金环蛇毒抗菌肽能否成为下一个抗感染“明星” [N]. 中国科学报, 2019-01-21(5).</mixed-citation></ref></ref-list></back></article>